Regarding Bell and Moore, Intravenous ketamine for CRPS: Making too much of too little? Pain 2010;150:10-11

Pain

Volumn 151, Issue 2, 2010, Pages 556-

  Kirkpatrick, Anthony F ^a   Lubenow, Timothy ^b  

^a International Research Foundation for RSD/CRPS   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; MIDAZOLAM;

ALLODYNIA; CLINICAL PROTOCOL; COMPLEX REGIONAL PAIN SYNDROME; DRUG DOSE INCREASE; HEALTH CARE COST; HUMAN; LETTER; OUTPATIENT; PRIORITY JOURNAL;

ANALGESICS; COMPLEX REGIONAL PAIN SYNDROMES; HUMANS; INJECTIONS, INTRAVENOUS; KETAMINE;

EID: 77957895178     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.08.019     Document Type: Letter

References (3)

1. R.F. Bell, and R.A. Moore Intravenous ketamine for CRPS: making too much of too little? Pain 150 2010 10 11
2. P.M. Finch, L. Knudsen, and P.D. Drummond Reduction of allodynia in patients with complex regional pain syndrome: a double-blind placebo-controlled trial of topical ketamine Pain 146 2009 18 25
3. R.J. Schwartzman, G.M. Alexander, J.R. Grothusen, T. Paylor, E. Reichenberger, and M. Perreault Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study Pain 147 2009 107 115